ストックスクリーナーアプリを入手
8.74
3.19%
0.27
アフターアワーズ：
8.79
0.05
+0.57%
Immix Biopharma Inc (IMMX) 最新ニュース
IMMX Q1 2026 Earnings: Biotech Reports Narrower-than-Expected Loss, Shares GainEPS Estimate Trend - newsline.com
Immix Biopharma Surges 5.3% as Biotech Sentiment Lifts IMMXProfit Surge Picks - newsline.com
Wall Street analysts see a 120.59% upside in Immix Biopharma (IMMX): Can the stock really move this high? - MSN
What's going on with Immix Biopharma stock Thursday? - MSN
Janus Henderson files 13G/A: 9.09M shares of Immix Biopharma (IMMX) - Stock Titan
IMMX News | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
These 10 small-cap U.S. healthcare companies carry the market's most expensive valuations - Seeking Alpha
IMMX Technical Analysis | Trend, Signals & Chart Patterns | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
Immix Biopharma, Inc. Files Form 8-K Announcing Election of Directors and Corporate Details (May 2026) - Minichart
Immix Biopharma Shareholders Back Board and Auditor at AGM - TipRanks
Immix Biopharma (NASDAQ: IMMX) posts 2026 annual shareholder voting outcomes - Stock Titan
Immix Biopharma (IMMX) awards RSUs and stock options to director Helen Adams - Stock Titan
Immix Biopharma (IMMX) director Carey Ng awarded RSUs, 12,500-share option - Stock Titan
Immix Biopharma (NASDAQ: IMMX) grants RSUs and stock options to director - Stock Titan
Immix Biopharma (IMMX) CFO, President awarded 500,000 stock options at $8.78 - Stock Titan
Immix Biopharma (IMMX) director receives 6,250 RSUs and 12,500 options - Stock Titan
Immix Biopharma (IMMX) awards CEO 500,000 stock options at $8.78 strike - Stock Titan
Immix Biopharma (IMMX) director awarded RSUs and stock options in new grants - Stock Titan
Immix Biopharma (IMMX) board member receives new RSU and stock option awards - Stock Titan
Immix Biopharma (IMMX) director Jane Buchan awarded RSUs and 12,500 stock options - Stock Titan
Immix Biopharma (IMMX) Edges Higher as Biotech Sentiment ShiftsLiquidity Order Flow - newsline.com
Immix Biopharma Q1 2026 Earnings: Narrower-than-Expected Loss Drives Modest Stock UptickQuarterly Profit Report - newsline.com
Wall Street Analysts See a 120.59% Upside in Immix Biopharma (IMMX): Can the Stock Really Move This High? - Yahoo Finance
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX) - The Globe and Mail
Mizuho Securities Maintains Immix Biopharma(IMMX.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Immix Biopharma closes $140.65 million offering - The Pharma Letter
Immix Biopharma stock price target raised to $20 by H.C. Wainwright on trial data - Investing.com Nigeria
IMMX Q1 2026 Earnings: Narrowed Loss as Biotech Advances Oncology PipelineEarnings Outlook Update - Newser
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock - The Manila Times
Immix Biopharma closes $140.65 million stock offering By Investing.com - Investing.com Australia
Immix Biopharma Announces Closing of $150 Mil - Moomoo
Immix Biopharma closes $140.65 million stock offering - Investing.com UK
IMMX Maintained by HC Wainwright & Co. -- Price Target Raised to $20 - GuruFocus
Immix Biopharma, Inc. Closes $140.65 Million Underwritten Registered Offering of Common Stock - Quiver Quantitative
Biotech Immix Biopharma pulls in $140.65M from new stock sale - Stock Titan
Immix Biopharma Is Maintained at Buy by HC Wainwright & Co. - Moomoo
Immix Biopharma Price Target Raised to $20.00/Share From $15.00 by HC Wainwright & Co. - Moomoo
Immix Biopharma price target raised to $20 from $15 at H.C. Wainwright - TipRanks
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock - Sahm
Immix Biopharma Announces $150 Million Stock Offering to Fund NXC-201 AL Amyloidosis Therapy Development - Minichart
Immix Biopharma Raises $150 Million to Advance NXC-201 - TipRanks
Immix Biopharma (NASDAQ: IMMX) prices $150M common stock sale - Stock Titan
Immix Biopharma (IMMX) to raise ~$140.7M net via 16.78M-share sale - Stock Titan
What's Going On With Immix Biopharma Stock Thursday? - Benzinga
Immix Biopharma Prices $150 Million Stock Offering - Moomoo
Immix Biopharma prices $150 million stock offering at $8.94 By Investing.com - Investing.com South Africa
Immix Biopharma reports 95% complete response rate in trial By Investing.com - Investing.com South Africa
Sector Update: Healthcare - Moomoo
Immix Biopharma prices $150 million stock offering at $8.94 - Investing.com
1.27%
1.43%
大文字化:
|
ボリューム (24 時間):